Skip to main content#
Glendon Campus Alumni Research Giving to York Media Careers International York U Lions Accessibility
Future Students Current Students Faculty and Staff
Faculties Libraries York U Organization Directory Site Index Campus Maps
Graduate Program in Biology

>> Faculty


Peter Cheung

PhD (McMaster)
Assistant Professor

E-mail: pmcheung@yorku.ca

Research Areas:Molecular Biology and Biochemistry, Chromatin and Epigenetics

 

The nucleus of a murine fibroblast expressing H2A.Z-GFP. Metaphase chromosomes stained for DNA (blue), histone H2A.Z (red), histone H3-triMeK27 (green).

Research Interests and Goals

Regulation of gene expression is a fundamental biological process that determines growth, differentiation, identity and function of all cells. Our laboratory uses a combination of molecular biology and biochemistry techniques to dissect the mechanisms that regulate mammalian gene expression through histone proteins and post-translational modifications of chromatin.

In particular, we focus on histone phosphorylation, methylation and ubiquitylation, processes that act as molecular switches to both regulate and fine-tune gene transcription.

Our goals are to dissect the molecular details of how these modifications on various histones and histone variants work individually, as well as how they work together in combinations to diversify the regulatory outcomes on different cell functions.

Achieving these goals will not only yield greater insights into basic cell biology principles, but will also impact on our understanding of cancer and other diseases caused by dysregulation of gene expression.

The Cancer-Chromatin Connection

Cancer is often caused by dysregulated expression of oncogenes or tumour suppressor genes. Post-translational modifications of histone proteins is one of the fundamental mechanisms that regulates gene expression.

In the context of the human genome, DNA is complexed with histone proteins to form nucleosomes and chromatin (Figure 1). This functional organization of the genome is tightly regulated to ensure the appropriate gene expression patterns.

http://www.chromatintoronto.ca/chromatin.png 

Active genes are located in euchromatin. Euchromatin has an open structure, which allows transcription factors to bind the promoters of these genes. Conversely, inactive genes are sequestered into compact structures called heterochromatin where they are silenced.

Disruption of this balance between euchromatin and heterochromatin can have disastrous effects on normal cell functions, and can lead to unrestricted cell growth, resulting in the development of cancer.

Our Focus

Our lab utilizes a combination of molecular biology and biochemistry techniques to dissect the mechanisms of how histones and histone modifications regulate gene functions.

We have two main questions:

  1. How do signal transduction pathways converge onto histones to regulate gene functions?
  2. How do histone variants function in the epigenetic regulation of gene expression?

Current Projects

To address how signal transduction pathways converge onto histones to regulate gene expression we are are studying the role of H3 phohorylation in the activation of immediate-early genes in mammalian cells.

The Role of Histone H3 Phosphorylation in Gene Activation

Upon growth factor stimulation, the MAP kinase pathway is activated and ultimately converges onto chromatin resulting in the phosphorylatin of H3 at two specific serine resides (S10 and S28). These phosphorylation events are very rapid and transient, and correlate with the transcriptional activation of genes such as c-fos and c-jun (Figure 1).

The mechanism of transcriptional activation by phosphorylated S10 and/or S28 remains unclear. Currently, we are testing the significance of phosphorylation at these two sites and how they interact with the transcriptional machinary to regulate immediate-early gene expression.

Figure 1.

Our previous work (Cheung et al., 2000) showed that H3 phosphorylation promotes acetylation on the same histone and that these modifications function together to activate gene expression (Figure 2). This idea that histone modifications can work in combinations was formally described as the Histone Code Hypothesis (Strahl and Allis, 2000).

Figure 2.

In addition, we are also developing new techniques and assays to dissect the intricate interplay between histone modifications in vivo.

To study the role of histone variants in the epigenetic regulation of gene expression, we are studying the H2A variant, H2A.Z.

Histone Variant H2A.Z and Epigenetic Regulation of Gene Expression

H2A.Z is the only histone variant that is essential for cell viability. Knocking down H2A.Z expression by RNAi in mammalian cells leads to cell death or senescence.

Cumulative evidence suggests that this H2A variant has both positive and negative regulatory effects on gene expression. H2A.Z localizes to the transcription start sites of genes and we have found that a fraction of H2A.Z is modified by a single ubiquitin group. Monoubiquitylated H2A.Z is associated with transcriptionally silenced heterochromatin, and is linked to polycomb silencing.

Currently, we are testing how addition or removal of the ubiquitin modification on H2A.Z regulates transcription and gene expression.

Our Publications

  • Histone phosphorylation: chromatin modifications that link cell signaling pathways to nuclear function regulation

Lau, P. and Cheung, P. (Book Chapter) The Handbook of Cell Signaling. In press

Sarcinella, E., Zuzarte, P.C., Lau, P.N., Draker, R. and Cheung, P. Mol Cell Biol. 2007 Sep;27(18):6457-68.http://www.chromatintoronto.ca/PDFicon.png

  • Chromatin immunoprecipitation assay for mammalian tissues

Turner, F.B., Cheung, W.L., Cheung, P. Methods in Molecular Biology: Nuclear Programming. 2005 325: 261-272.

Cheung, P. and Lau, P. Mol Endocrinol. 2005 Mar;19(3):563-73. Review.http://www.chromatintoronto.ca/PDFicon.png

Barber, C.M., Turner, F.B., Wang, Y., Hagstrom, K., Taverna, S.D., Mollah, S., Ueberheide, B., Meyer, B.J., Hunt,D.F., Cheung, P. and Allis,D.C. Chromosoma. 2004 May;112(7):360-71.http://www.chromatintoronto.ca/PDFicon.png

  • Generation and characterization of antibodies directed against di-modified histones, and comments on antibody and epitope recognition

Cheung, P. Methods Enzmol. 2003 376: 221-234.

Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A., Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D. 2003 Cell. 113: 507-517.http://www.chromatintoronto.ca/PDFicon.png

Boggs, B.A., Cheung, P., Heard, E., Spector, D.L., Chinault,C.A. and Allis, D.C. Nat Genet. 2002 Jan;30(1):73-6.http://www.chromatintoronto.ca/PDFicon.png

Salvador, L.M., Park, Y., Cottom, J., Maizels, E.T., Jones, J.C. Schillace, R.V. Carr, D.W., Cheung, P., Allis, D.C. and Jameson, J.L., Hunzicker-Dunn, M. J Biol Chem. 2001 Oct 26;276(43):40146-55.http://www.chromatintoronto.ca/PDFicon.png

Cheung, p., Tanner, K.G., Cheung,W.L., Sassone-Corsi, P., Denu, J.M. and Allis, D.C. Mol Cell. 2000 Jun;5(6):905-15.http://www.chromatintoronto.ca/PDFicon.png

Cheung, P., Ellison, K.S., Verity, R., Smiley, J.R. J. Virol. 2000 74: 2913-2919.http://www.chromatintoronto.ca/PDFicon.png

Sassone-Corsi,P., Mizzen, C.A., Cheung, P., Crosio, C. Monaco, L., Jacquot, S., Hanauer, A. and Allis, D.C. Science. 1999 Aug 6;285(5429):886-91.http://www.chromatintoronto.ca/PDFicon.png

Cheung, P., Panning, B., and Smiley, J.R. 1997 J. Virol. 71: 1784-1793.http://www.chromatintoronto.ca/PDFicon.png